Johnson Johnson-covid-19-vaccine

Showing 1 of 5 from 5 results
Johnson Johnson-covid-19-vaccine - Total results - 5
US recommends ‘pause’ on administration of J&J's COVID-19 vaccine to investigate reports of blood clots
World

US recommends ‘pause’ on administration of J&J's COVID-19 vaccine to investigate reports of blood clots

CDC’s Advisory Committee on Immunisation Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases

Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s
World

Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s

JnJ's vaccine appears to be less prone than Pfizer-BioNTech's and Moderna's, to trigger the kinds of side effects that require monitoring.

Biological E to produce 600 mn doses of Johnson & Johnson COVID-19 vaccine a year:
World

Biological E to produce 600 mn doses of Johnson & Johnson COVID-19 vaccine a year:

Interim data for Biological E's own COVID-19 vaccine, still in clinical trials, is expected later this quarter.

WHO recognises 'concerning news' of COVID-19 vaccines not working against variants
World

WHO recognises 'concerning news' of COVID-19 vaccines not working against variants

Booster shots will likely be needed, since new virus variants are spreading globally and likely to become the predominant strains.

Some COVID-19 vaccine makers have declared their intentions to profit from the vaccine
News & Analysis

Some COVID-19 vaccine makers have declared their intentions to profit from the vaccine

Experts point out that the global distribution of a vaccine is necessary since none of us is safe until all of us are safe.